Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $92.92 | $118.84B | $249.82B | $402.07B | $9.41B | $1.77B | 66.85x | 0.30x | 20.15x |
WM WMT Walmart Inc. FY ended Mar 11, 2026 | $102.63 | $816.74B | $957.53B | $713.16B | $40.29B | $21.89B | 37.59x | 1.15x | 23.77x |
KR KR KROGER CO FY ended Mar 25, 2026 | $56.93 | $34.88B | $59.73B | $147.64B | $1.66B | $1.02B | 36.97x | 0.24x | 20.71x |
CI CI Cigna Group FY ended Jan 30, 2026 | $277.67 | $73.37B | $141.91B | $274.90B | $10.87B | $6.29B | 12.52x | 0.27x | 13.05x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $395.05 | $354.59B | $432.71B | $447.57B | $20.65B | $12.06B | 29.86x | 0.79x | 16.40x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 19.43x | 5/5 | -$124.84B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.55x | 5/5 | $80.80B | $93.36 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 36.76x | 5/5 | -$317.44B | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $92.92 | $118.84B | $249.82B | $402.07B | $9.41B | $1.77B | 66.85x | 0.30x | 20.15x |
WM WMT Walmart Inc. FY ended Mar 11, 2026 | $102.63 | $816.74B | $957.53B | $713.16B | $40.29B | $21.89B | 37.59x | 1.15x | 23.77x |
KR KR KROGER CO FY ended Mar 25, 2026 | $56.93 | $34.88B | $59.73B | $147.64B | $1.66B | $1.02B | 36.97x | 0.24x | 20.71x |
CI CI Cigna Group FY ended Jan 30, 2026 | $277.67 | $73.37B | $141.91B | $274.90B | $10.87B | $6.29B | 12.52x | 0.27x | 13.05x |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $395.05 | $354.59B | $432.71B | $447.57B | $20.65B | $12.06B | 29.86x | 0.79x | 16.40x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 19.43x | 5/5 | -$124.84B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.55x | 5/5 | $80.80B | $93.36 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 36.76x | 5/5 | -$317.44B | — | Target fundamentals do not produce a usable positive equity value. |
